Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease

Published:2017-12-28 Issue:6 Volume:117 Page:1170-1178
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Karydis Ioannis¹²^ORCID,Gangi Alexandra³^ORCID,Wheater Matthew J.²,Choi Junsung⁴,Wilson Iain²,Thomas Kerry⁴,Pearce Neil²,Takhar Arjun²,Gupta Sanjay²,Hardman Danielle⁵,Sileno Sean⁵,Stedman Brian²,Zager Jonathan S.³,Ottensmeier Christian¹²

Affiliation:

1. Cancer Sciences Academic Unit; University of Southampton; Southampton United Kingdom

2. University Hospital Southampton; Southampton United Kingdom

3. Department of Cutaneous Oncology; Moffitt Cancer Center; Tampa Florida

4. Department of Radiology; Moffitt Cancer Center; Tampa Florida

5. Morsani School of Medicine; University of South Florida; Tampa Florida

Funder

NIHR Southampton Experimental Medicine Centre

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference24 articles.

1. Survival of patients with metastases from uveal melanoma;Gragoudas;Ophthalmology,1991

2. Prognosis and treatment of disseminated uveal melanoma;Kath;Cancer,1993

3. Collaborative Ocular Melanoma Study Group, development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26;Diener-West;Arch Ophthalmol,2005

4. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

5. Overall survival and durable responses in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib combined with trametinib;Long;J Clin Oncol,2016

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma;Annals of Surgical Oncology;2024-08-22

2. Clinical Characteristics and Special Considerations in the Management of Rare Melanoma Subtypes;Cancers;2024-06-28

3. The Current State of Systemic Therapy of Metastatic Uveal Melanoma;American Journal of Clinical Dermatology;2024-06-22

4. Intralesional and Infusional Updates for Metastatic Melanoma;Cancers;2024-05-22

5. Successful application of chemosaturation with percutaneous hepatic perfusion in metastatic uveal melanoma patient progressing after systemic treatment options: a case report;Frontiers in Oncology;2024-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3